CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy
Small · 2024-10 · 20 (40)
DOI: 10.1002/smll.202400326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 30.05.2024. Verfasst von Jinwei Bai und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Applied Organic Chemistry and Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, Colle…. Hauptthemen laut MEDLINE: Ferroptosis, Cysteine, Copper, Glutathione. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Science and Technology Project of Gansu Province.
Abstract (Originalsprache)
The latest research identifies that cysteine (Cys) is one of the key factors in tumor proliferation, metastasis, and recurrence. The direct depletion of intracellular Cys shows a profound antitumor effect. However, using nanozymes to efficiently deplete Cys for tumor therapy has not yet attracted widespread attention. Here, a (3‐carboxypropyl) triphenylphosphonium bromide‐derived hyaluronic acid‐modified copper oxide nanorods (denoted as MitCuOHA) are designed with cysteine oxidase‐like, glutathione oxidase‐like and peroxidase‐like activities to realize Cys depletion and further induce cellular ferroptosis and cuproptosis for synergistic tumor therapy. MitCuOHA nanozymes can efficiently catalyze the depletion of Cys and glutathione (GSH), accompanied by the generation of H 2 O 2 and the subsequent conversion into highly active hydroxyl radicals, thereby successfully inducing ferroptosis in cancer cells. Meanwhile, copper ions released by MitCuOHA under tumor microenvironment stimulation directly bind to lipoylated proteins of the tricarboxylic acid cycle, leading to the abnormal aggregation of lipoylated proteins and subsequent loss of iron–sulfur cluster proteins, which ultimately triggers proteotoxic stress and cell cuproptosis. Both in vitro and in vivo results show the drastically enhanced anticancer efficacy of Cys oxidation catalyzed by the MitCuOHA nanozymes, demonstrating the high feasibility of such catalytic Cys depletion‐induced synergistic ferroptosis and cuproptosis therapeutic concept.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Applied Organic Chemistry and Key Laboratory of Nonferrous Metal Chemistry and Resources Utilization of Gansu Province, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou,…
ORCID-Profile: Baodui Wang
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Science and Technology Project of Gansu Province
- National Key Research and Development Program of China
Zitieren
APA
Bai, J., Zhang, X., Zhao, Z., Sun, S., Cheng, W., Yu, H., Chang, X., & Wang, B. (2024). CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy. Small, 20(40). https://doi.org/10.1002/smll.202400326
Vancouver
Bai J, Zhang X, Zhao Z, Sun S, Cheng W, Yu H, et al. CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy. Small. 2024;20(40). doi:10.1002/smll.202400326
BibTeX
@article{Bai2024,
author = {Bai, Jinwei and Zhang, Xuan and Zhao, Zhiwen and Sun, Shihao and Cheng, Wenyuan and Yu, Hongxiang and Chang, Xinyue and Wang, Baodui},
title = {CuO Nanozymes Catalyze Cysteine and Glutathione Depletion Induced Ferroptosis and Cuproptosis for Synergistic Tumor Therapy},
journal = {Small},
year = {2024},
volume = {20},
number = {40},
doi = {10.1002/smll.202400326}
}
EUVIMED